$LNBY
Landbay Inc

2023 Q4 Form 10-Q Financial Statement

#000149315223039995 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $1.102K $3.178K
YoY Change -82.66%
Cost Of Revenue $850.00 $2.872K
YoY Change -83.5%
Gross Profit $252.00 $306.00
YoY Change -79.1%
Gross Profit Margin 22.87% 9.63%
Selling, General & Admin $7.990K $8.100K $7.050K
YoY Change -14.27% 14.89% -25.55%
% of Gross Profit 3170.63% 2647.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $7.988K $8.095K $7.048K
YoY Change -14.25% 14.86% -25.58%
Operating Profit -$7.736K -$7.789K -$7.048K
YoY Change -4.6% 10.51% -21.43%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $14.00 -$57.00
YoY Change -6.67%
Pretax Income -$7.720K -$7.850K -$7.050K
YoY Change -4.57% 11.35% -15.06%
Income Tax
% Of Pretax Income
Net Earnings -$7.722K -$7.846K -$7.048K
YoY Change -4.6% 11.32% -15.08%
Net Earnings / Revenue -700.73% -246.88%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$235.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares 30.00M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.020K $5.460K $3.900K
YoY Change 46.6% 40.0% -91.65%
Cash & Equivalents $3.016K $5.462K $3.899K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.772K $4.622K $11.27K
Prepaid Expenses
Receivables
Other Receivables $0.00
Total Short-Term Assets $6.788K $10.08K $15.17K
YoY Change -55.04% -33.5% -73.56%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.788K $10.08K $15.17K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $6.788K $10.08K $15.17K
YoY Change -55.04% -33.5% -73.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.500K $2.500K
YoY Change -27.18%
Deferred Revenue
YoY Change
Short-Term Debt $121.8K $116.2K $82.37K
YoY Change 37.88% 41.05% 1.57%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $123.4K $119.0K $82.37K
YoY Change 36.51% 44.43% 1.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $123.4K $119.0K $82.37K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $123.4K $119.0K $82.37K
YoY Change 36.51% 44.43% 1.42%
SHAREHOLDERS EQUITY
Retained Earnings -$472.3K -$464.5K -$422.9K
YoY Change 9.59% 9.86%
Common Stock $30.00K $30.00K $30.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$116.6K -$108.9K -$67.20K
YoY Change
Total Liabilities & Shareholders Equity $6.788K $10.08K $15.17K
YoY Change -55.04% -33.5% -73.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$7.722K -$7.846K -$7.048K
YoY Change -4.6% 11.32% -15.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$8.060K $11.94K -$23.85K
YoY Change 3.33% -150.06% 192.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.610K 9.500K 1.270K
YoY Change -5.87% 648.03%
NET CHANGE
Cash From Operating Activities -8.060K 11.94K -23.85K
Cash From Investing Activities 0.000
Cash From Financing Activities 5.610K 9.500K 1.270K
Net Change In Cash -2.450K 21.44K -22.58K
YoY Change 33.15% -194.95% -151.04%
FREE CASH FLOW
Cash From Operating Activities -$8.060K $11.94K -$23.85K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001672572
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56182
dei Entity Registrant Name
EntityRegistrantName
Landbay Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1260549
dei Entity Address Address Line1
EntityAddressAddressLine1
36-25 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
232-5799
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30000000 shares
CY2023Q3 us-gaap Cash
Cash
5462 usd
CY2023Q1 us-gaap Cash
Cash
8105 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4622 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
7494 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
10084 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
15599 usd
CY2023Q3 us-gaap Assets
Assets
10084 usd
CY2023Q1 us-gaap Assets
Assets
15599 usd
CY2023Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
281 usd
CY2023Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
398 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2500 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
116184 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
99456 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
118965 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
99854 usd
CY2023Q3 us-gaap Liabilities
Liabilities
118965 usd
CY2023Q1 us-gaap Liabilities
Liabilities
99854 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
30000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325659 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464540 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-439914 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-108881 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10084 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15599 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3178 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3178 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7348 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2872 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2872 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
306 usd
us-gaap Gross Profit
GrossProfit
306 usd
us-gaap Gross Profit
GrossProfit
7348 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8095 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7048 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24895 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27961 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
8095 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7048 usd
us-gaap Operating Expenses
OperatingExpenses
24895 usd
us-gaap Operating Expenses
OperatingExpenses
27961 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7789 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7048 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24589 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-20613 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7846 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7048 usd
us-gaap Net Income Loss
NetIncomeLoss
-24626 usd
us-gaap Net Income Loss
NetIncomeLoss
-20613 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-84255 usd
us-gaap Net Income Loss
NetIncomeLoss
-24626 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-108881 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-46588 usd
us-gaap Net Income Loss
NetIncomeLoss
-20613 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-67201 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-101035 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7846 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-108881 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-60153 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-60153 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7048 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-67201 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-67201 usd
us-gaap Net Income Loss
NetIncomeLoss
-24626 usd
us-gaap Net Income Loss
NetIncomeLoss
-20613 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9115 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2500 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2872 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11266 usd
LNBY Increase Decrease In Other Tax Payable
IncreaseDecreaseInOtherTaxPayable
-117 usd
LNBY Increase Decrease In Other Tax Payable
IncreaseDecreaseInOtherTaxPayable
-743 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19371 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23507 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16728 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1266 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16728 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1266 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2643 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22241 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8105 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26140 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5462 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3899 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
743 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zkyfBorocrK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zs6E6Kuo1tD6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts and timing of revenues and expenses, the reported amounts and classification of assets and liabilities, and the disclosure of contingent assets and liabilities. Significant areas requiring the use of estimates are assessing the allowance of doubtful account and collectible of notes receivable. These estimates and assumptions are based on the Company’s historical results as well as management’s future expectations. The Company’s actual results may vary from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
116184 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
99456 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7846 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7048 usd
us-gaap Net Income Loss
NetIncomeLoss
-24626 usd
us-gaap Net Income Loss
NetIncomeLoss
-20613 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
112000 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
86568 usd

Files In Submission

Name View Source Status
0001493152-23-039995-index-headers.html Edgar Link pending
0001493152-23-039995-index.html Edgar Link pending
0001493152-23-039995.txt Edgar Link pending
0001493152-23-039995-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lnby-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lnby-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
lnby-20230930_def.xml Edgar Link unprocessable
lnby-20230930_cal.xml Edgar Link unprocessable
lnby-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed